SOPHARMA (SPH): NOTIFICATION - raport 119
Raport ESPI
UNI - EN REPORT No119/2013
Sopharma AD (the “Company”) notifies that for August 2013 the Company realized a decrease of sales revenues of 8% compared to the same period of 2012, as a result of retained level of domestic sales and 12% decrease of export sales.
During the past eight months Sopharma AD recorded a decrease of sales revenues of 2%, including 4% increase of domestic sales and 5% decrease of export sales compared to the same period of 2012.
